ALDH1 is an independent prognostic factor for patients with stages II–III rectal cancer after receiving radiochemotherapy

ALDH1 expression indicates chemotherapy resistance and poor outcome in node-negative rectal cancer

(2013) S. Tuulia Avoranta et al.   HUMAN PATHOLOGY

Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival

(2012) Thilo Sprenger et al.   CANCER

Transition from Colitis to Cancer: High Wnt Activity Sustains the Tumor-Initiating Potential of Colon Cancer Stem Cell Precursors

(2012) A. K. Shenoy et al.   CANCER RESEARCH

ALDH+ tumor-initiating cells exhibiting gain in NOTCH1 gene copy number have enhanced regrowth sensitivity to a γ-secretase inhibitor and irinotecan in colorectal cancer

(2012) John J. Arcaroli et al.   Molecular Oncology

Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells

(2012) Kristel Kemper et al.   STEM CELLS

5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells

(2012) Yan-Hong Deng et al.   Chinese Journal of Cancer

Clinical Significance of Circulating Tumor Cells, Including Cancer Stem-Like Cells, in Peripheral Blood for Recurrence and Prognosis in Patients With Dukes' Stage B and C Colorectal Cancer

(2011) Hisae Iinuma et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM and ALDH1 in colorectal cancer

(2010) A Lugli et al.   BRITISH JOURNAL OF CANCER

Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis

(2009) E. H. Huang et al.   CANCER RESEARCH

Cancer Stem Cells: A Step Toward the Cure

(2008) Bruce M. Boman et al.   JOURNAL OF CLINICAL ONCOLOGY

Colorectal Cancer Stem Cells Are Enriched in Xenogeneic Tumors Following Chemotherapy

(2008) Scott J. Dylla et al.   PLoS One